CELEX: 62011CB0442
Language: en
Date: 2012-02-09 00:00:00
Title: Case C-442/11: Order of the Court (Eighth Chamber) of 9 February 2012 (reference for a preliminary ruling from the High Court of Justice (Chancery Division) (United Kingdom) — Novartis AG v Actavis UK Ltd (The first subparagraph of Article 104(3) of the Rules of Procedure — Medicinal products for human use — Supplementary protection certificate — Regulation (EC) No 469/2009 — Articles 4 and 5 — Sole active ingredient for which such a certificate is granted — Scope of protection — Medicinal product containing more than one active ingredient, including the active ingredient which is the subject of a certificate)

5.5.2012   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 133/12
            
         Order of the Court (Eighth Chamber) of 9 February 2012 (reference for a preliminary ruling from the High Court of Justice (Chancery Division) (United Kingdom) — Novartis AG v Actavis UK Ltd
   (Case C-442/11) (1)
   
   (The first subparagraph of Article 104(3) of the Rules of Procedure - Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Articles 4 and 5 - Sole active ingredient for which such a certificate is granted - Scope of protection - Medicinal product containing more than one active ingredient, including the active ingredient which is the subject of a certificate)
   2012/C 133/22
   Language of the case: English
   
      Referring court
   
   High Court of Justice (Chancery Division)
   
      Parties to the main proceedings
   
   
      Applicant: Novartis AG
   
      Defendant: Actavis UK Ltd
   
      Re:
   
   Reference for a preliminary ruling — High Court of Justice (Chancery Division) — Interpretation of Articles 4 and 5 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (OJ 2009 L 152, p. 1) — Scope of the certificate — Protection only of medicinal products containing the protected active ingredient alone or protection also of medicinal products containing the protected active ingredient in combination with another active ingredient
   
      Operative part of the order
   
   Articles 4 and 5 of Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products must be interpreted as meaning that, where a ‘product’ consisting of an active ingredient was protected by a basic patent and the holder of that patent was able to rely on the protection conferred by that patent for that ‘product’ in order to oppose the marketing of a medicinal product containing that active ingredient in combination with one or more other active ingredients, a supplementary protection certificate granted for that ‘product’ enables its holder, after the basic patent has expired, to oppose the marketing by a third party of a medicinal product containing that product for a use of the ‘product’, as a medicinal product, which was authorised before that certificate expired.
   
      (1)  OJ C 311, 22.10.2011.